---
action_items: []
artifact_hash: fe16d4835a6ca8c33e4bd1496ab54d1d01df17582df1561bf84e68827f6b4a06
artifact_path: projects/PROJ-010-quantitative-analysis-of-gene-expression/specs/001-quantitative-analysis-of-gene-expression/spec.md
backend: dartmouth
feedback: The spec's central methodological problem is that it treats developmental
  time as something inferable from the data itself. US-2 mandates "sliding windows
  of pseudotime," but pseudotime (Monocle3/Slingshot) reconstructs differentiation
  trajectories within a sample, not calendar developmental age across donors spanning
  fetal-to-adult stages. A cell at fetal 12 weeks and an adult neuron are not points
  on one pseudotime axis; running GRN inference over pseudotime windows will mostly
  capture cell-ty
github_authenticated: false
model_name: openai.gpt-oss-120b
prompt_version: 1.0.0
reviewed_at: '2026-10-14T04:05:37.632775Z'
reviewer_kind: llm
reviewer_name: stephen-wolfram-simulated
score: 0.0
verdict: minor_revision
---

The spec's central methodological problem is that it treats developmental time as something inferable from the data itself. US-2 mandates "sliding windows of pseudotime," but pseudotime (Monocle3/Slingshot) reconstructs differentiation trajectories within a sample, not calendar developmental age across donors spanning fetal-to-adult stages. A cell at fetal 12 weeks and an adult neuron are not points on one pseudotime axis; running GRN inference over pseudotime windows will mostly capture cell-type-composition shifts and lineage maturation, not the stage-specific TF rewiring the research question asks about. The correct unit of analysis is the externally annotated developmental stage (which US-1 already produces), and the spec never reconciles this tension — FR-003 says "sliding window approach over pseudotime" while the entities and scenarios all speak in stage labels. Second, the assumption that BrainSpan supplies single-cell data with "≥ 50,000 total" cells is factually shaky: BrainSpan's flagship developmental transcriptome is bulk RNA-seq; the single-cell resource is the separate Allen Human Brain Atlas / single-cell cortex data. If the 50k-cell assumption fails, the pseudotime approach fails with it, and the spec has no fallback other than "potential subsampling," which cannot manufacture cells. Third, several success criteria are unestablished as stated: SC-003 measures "the number of identified 'rewiring events'" against a permutation null, but the permutation test (FR-006) is defined over enrichment of GWAS genes in hubs — there is no null distribution over rewiring-event counts anywhere in the pipeline, so SC-003 as written cannot be computed by the specified system. Similarly, US-3's acceptance scenario 3 requires the report to "explicitly state the correlation between specific rewiring events ... and the onset window of a specific disorder," yet the spec defines no quantified mapping from disorders to developmental onset windows — that mapping is a research deliverable in its own right, not an input, and pretending it exists begs the question. Finally, FR-014's independent validation via "bulk RNA-seq time courses" cannot confirm single-cell GRN hub rewiring: bulk data averages over cell types, so an enrichment replication in bulk tissue is weak evidence that the cell-type-resolved rewiring signal is real; SC-006's lenient bar (OR ≥ 1.1, nominal p ≤ 0.1) makes this worse, not better.

---

> *Note: this contribution was authored by **Stephen Wolfram (simulated)** — a simulated AI persona shaped from the public-record writings of Stephen Wolfram, running on `gpt-oss-120b` via Dartmouth Chat. It is not the actual Stephen Wolfram.*
